标签： 上海私人品茶

The official micro-release of "China Table Tennis Fight Back" said that the film will be adjusted to a small-scale screening from January 25th/Lunar New Year’s Day, and will resume normal screening on February 17th. The film was released on January 24 this year (the third day of the New Year’s Eve) and ended on the 25th, with a box office of 40.36 million yuan in two days.

This kind of operation, for ordinary people, is really an eye-opener. After seeing a movie for the first time for half a day, I quickly saw that the situation was wrong and hurriedly withdrew the file.

When Guanbo announced the news on Weibo, the wording was very ambiguous and vague, which sounded grandiose, as if to say that there was something wrong with his announcement. But the truth was revealed by some netizens because many cinemas didn’t give China Ping-Pong a chance to be screened at midnight in the underworld, so there was no good screening time, and naturally no one bought a ticket. Seeing that the box office trend is likely to fail to recover the cost, the film side quickly retreated when it saw a bad opportunity.

As soon as the box office was in a mess, he avoided the limelight first, which caused a lot of noise. For a while, the attention of this film was unprecedented. As a matter of fact, before the film was released, because of its embarrassment in these aspects, there have been quite a few tossing, and the subsequent operation has exposed many problems.

The first embarrassment is the embarrassment of its subject matter.

Sports theme is actually a necessary evergreen topic in the film genre. It is reasonable to say that it is not an unpopular and niche thing. But the problem is, it’s about ping pong, the sports strength of China people.

Looking back on the wonderful table tennis matches in China, there can be 180 games a year, and the film is incapable of recreating the wonderful moments of the real table tennis match. Take these young actors who are used in movies as an example. They usually shoot idol dramas with poor attitude, lack of professionalism and insufficient acting skills, not to mention watching them play serious table tennis players in movies. Just a little, it is a big problem to see if their table tennis posture can meet the standard.

Compared with Leap, who told you the story of China volleyball before, the story of China women’s volleyball team has its ups and downs, which is strong enough in itself. It is not as difficult to shoot as China’s table tennis, and it still has not achieved good box office results and word of mouth, not to mention China Table Tennis.

Furthermore, you can finish the film in one sentence, practice the Jedi counterattack hard when you encounter a trough, and finally climb the peak. Everyone is happy and applauding. It seems that it is also a very old-fashioned shooting technique, and it is difficult to be innovative.

The second embarrassment is the director’s embarrassment.

On the eve of the release of China Ping Pong, People’s Daily interviewed two directors, Deng Chao and Yu Baimei. The content of the interview, left is just that set of fixed words, about the original intention of shooting this film, how difficult it is for them to film, and what kind of effect will they show in the end.

However, in the face of this topic, many netizens’ attitudes throughout their lives are: Deng Chao and Yu Baimei are true love, while Sun Li is an accident.

This sentence is actually a little malicious ridicule. Deng Chao and Yu Baimei tied together and brought a lot of junk movies. Even if the film was well arranged, people wouldn’t go to the cinema to watch them at the first time. This is really because the PTSD they gave everyone was too deep. Take a look at the famous bad movies in China’s film history, and the inevitable "Villain Angel" is brought to you by two people. Besides, two people are rotten and don’t know it. I always feel that other people don’t understand the two of them. It seems that the whole audience in China owes them, and they jump up and down when the box office is a little bad. All talk is socialism, but all business is in my heart.

The third embarrassment is the embarrassing schedule.

At first, it was New Year’s Day, and then it was changed to New Year’s Day. This time, it simply withdrew from the Spring Festival file and was rescheduled for February 17.

In order to avoid the two blockbusters "Wandering Earth 2" and "Man Jiang Hong" and prevent them from dying miserably in the fight between the boss and the second child, they chose another schedule. But it’s still the same sentence: if you can hide from the first grade, can you hide from the fifteenth? Later, Marvel Comics returned to the palace, Black Panther on February 7, Ant Man 3 on February 17, and When the Wind Comes Again (actors include Aaron Kwok, Tony Leung Chiu Wai, Du Fu, Tan Yaowen and Ng Cheuk Hai) on February 24. It is said that Titanic will be released again on Valentine’s Day. In case the situation is not good again, the two films "Wandering Earth 2" and "Man Jiang Hong" will be postponed for more than a month, and it will still have to face these opponents. In addition, looking back, how many films were good when they ran away from the enemy?

Douban gave the film seven points, almost average, neither up nor down, neither good nor bad, and left the film with an embarrassment.

Who can cross the confused winter and become the next king of business in the medical and health industry?

Recently, 36Kr WISE2023 "Looking for certainty" King of Business-New Trends of Medical Health was held in Beijing. The conference joined hands with scientists, entrepreneurs and investors to find the "certainty" of the industry worth betting on from the real clinical needs and technological innovation.

Medical health is a track that can cross the cycle and has great development potential. It needs the investment of "1 billion dollars in 10 years" and the hard work of being willing to sit on the bench. At present, China’s basic research ability is booming, and innovative forces are rising. In the great changes, the new generation of enterprises are focusing on the real pain points in clinic, breaking through the technical bottleneck, crossing the market difficulties and risks, step by step, and achieving a win-win situation of social value and commercial value through innovative products and services.

In the opening speech session, Yang Li, chief content officer of 36Kr, mentioned that the number of elderly people over 65 in China has reached 210 million, aging and diseases are issues that must be faced directly, and the market is always calling for medical products and services with real clinical value, which makes everyone firmly believe that the medical and health industry is a trillion-dollar sunrise industry.

She pointed out that in the past, innovative pharmaceutical companies in China seized the opportunity of several super-large targets, which stimulated the expansion of the biomedical industry in China. However, with the maturity of the payer and the capital market, it is difficult to obtain a high premium for the micro-innovation that followed in the past; At present, only the medical instruments that are significantly superior to the original treatment plan in clinical effectiveness and safety can really stand out.

Yang Li, Chief Content Officer of 36Kr

The following is a speech by Ms. Yang Li, Chief Content Officer of 36Kr, edited by 36Kr:

If you are a sci-fi fan, these movies must be familiar.

In The Matrix, human beings in the real world can insert connectors behind their necks and enter the consciousness matrix of the "matrix". In "Avatar", scientists let the brain synchronize with Avatar’s body induction through the induction cabin; In Star Wars, the control of mechanical prostheses through ideas ….. all these vividly depict the super power of brain-computer interface in the future.

This year, Neuralink, Musk’s brain-computer interface company, was officially approved for human clinical trials. Thousands of patients with gradual freezing and spinal cord injury lined up to join the group, hoping to implant electrodes and chips in the brain to regain their motor ability. In China, a number of startups have emerged to develop invasive brain-computer interfaces, which have been favored by investment institutions and are developing more indications. The cutting-edge technological innovation represented by brain-computer interface is the source of vitality of medical and health industry.

Biomedicine is a track with high investment and high risk. However, this year’s popularity of a "magic medicine", Smegrupeptide, has made ordinary people realize how high the return of innovation in pharmaceutical research and development may be. This drug, which was originally used to reduce blood sugar, quickly came out of the circle because of its excellent performance in weight loss. In the first three quarters of 2023 alone, it contributed $14.2 billion to Novo Nordisk. It not only pulls the parent company’s market value beyond LV, but also becomes the current European enterprise market value champion; It also drove the investment boom of the entire GLP-1 receptor agonist track by itself.

The power of science and technology allows human beings to enter outer space, control large models and create billions of wealth. However, in the face of the one-way process of birth, illness and death, human strength is so weak. Up to now, there are still no effective drugs and solutions for common diseases such as nonalcoholic fatty liver and Alzheimer’s disease.

Nowadays, the number of elderly people over 65 in China has reached 210 million. Aging and diseases are issues that must be faced directly. The market is always calling for innovative drugs and medical devices that have real clinical value and can solve pain points. This is what we are willing to firmly believe: the medical and health industry is a trillion-dollar track and a sunrise industry.

However, since the first innovative drug was approved in China in 2011, the development history of innovative drugs in China is only 12 years. Seize the opportunity of several super-large targets, take advantage of local talents and cost advantages, and a number of innovative pharmaceutical companies rose rapidly and rushed to the market, which once stimulated the expansion of the biomedical industry in China.

However, with the maturity of the payer and the capital market, it is difficult to obtain a high premium for the micro-innovation that followed in the past. Only the medical instruments that are significantly superior to the original treatment plan in clinical effectiveness and safety can really stand out.

It is optimistic that China’s basic research ability is booming, and the original innovation ability of biomedicine has also made a qualitative leap, and the whole industrial chain of R&D, design, production and registration supporting innovative medical equipment has also matured. In recent years, China’s innovative drugs and machinery have gradually become a majestic trend, and many enterprises have rushed out of the tight encirclement in the global competition and got a lot of business transcripts.

It can be said that world-class medical companies are being bred in China at present.

Indeed, the phenomenon of "stuck neck" is still common, the trend of medical insurance control fees is still continuing, the enthusiasm of capital has also subsided, and the entrepreneurial game in the pharmaceutical industry has switched to a difficult mode, full of various uncertainties. However, all the guests present are still willing to bend down and enter such a slow but bright track, using medical technology as a spear to overcome stubborn diseases.

The more you are in such a cold winter, the more you need to hold a group to keep warm. Today, we chose a representative medical subdivision track and invited more than 30 entrepreneurs and investors in the frontier medical science and technology field to talk about the inspiration and persistence of medical technology innovation, as well as the uneven road of admission and commercialization.

The fog will eventually disperse, and the winter will eventually pass. The theme of this year’s 36Kr WISE Medical Sub-forum is "Looking for certainty". We hope to sum up the coming 2023, predict the trend of venture capital in the medical and health industry in 2024, and explore more valuable certainty creed. Believe that the sun will eventually rise as usual!